Emergent BioSolutions Inc. [EBS] - appoints Frank Vargo as Interim CFO
Effective January 1, 2027, Frank Vargo will succeed Richard Lindahl as Interim Chief Financial Officer of Emergent BioSolutions Inc., who will step down on December 31, 2026, after over eight years in the role.
Why this matters
Generating analysis…